Results
|
24521.
|
Dose-proportionality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers. [electronic resource] by
- Bergman, Arthur
- Mistry, Goutam C
- Luo, Wen-Lin
- Liu, Q
- Stone, Julie
- Wang, Amy
- Zeng, Wei
- Chen, Li
- Dilzer, Stacy
- Lasseter, Kenneth
- Herman, Gary A
- Wagner, John A
- Krishna, Rajesh
Producer: 20071220
In:
Biopharmaceutics & drug disposition vol. 28
Availability: No items available.
|
|
24522.
|
|
|
24523.
|
|
|
24524.
|
|
|
24525.
|
|
|
24526.
|
|
|
24527.
|
|
|
24528.
|
|
|
24529.
|
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis. [electronic resource] by
- Sandborn, William J
- Regula, Jaroslaw
- Feagan, Brian G
- Belousova, Elena
- Jojic, Njegica
- Lukas, Milan
- Yacyshyn, Bruce
- Krzeski, Piotr
- Yeh, Chyon-Hwa
- Messer, Christi A
- Hanauer, Stephen B
Producer: 20091224
In:
Gastroenterology vol. 137
Availability: No items available.
|
|
24530.
|
Metabolism of loratadine and further characterization of its in vitro metabolites. [electronic resource] by
- Ghosal, Anima
- Gupta, Samir
- Ramanathan, Ragu
- Yuan, Yuan
- Lu, Xiaowen
- Su, Ai Duen Iris
- Alvarez, Narciso
- Zbaida, Shmuel
- Chowdhury, Swapan K
- Alton, Kevin B
Producer: 20091211
In:
Drug metabolism letters vol. 3
Availability: No items available.
|
|
24531.
|
|
|
24532.
|
|
|
24533.
|
|
|
24534.
|
|
|
24535.
|
|
|
24536.
|
|
|
24537.
|
Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. [electronic resource] by
- McClung, M R
- Miller, P D
- Brown, J P
- Zanchetta, J
- Bolognese, M A
- Benhamou, C L
- Balske, A
- Burgio, D E
- Sarley, J
- McCullough, L K
- Recker, R R
Producer: 20120321
In:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA vol. 23
Availability: No items available.
|
|
24538.
|
|
|
24539.
|
|
|
24540.
|
|